Stay updated on Combination Immunotherapy for Melanoma Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Combination Immunotherapy for Melanoma Brain Metastases Clinical Trial page.

Latest updates to the Combination Immunotherapy for Melanoma Brain Metastases Clinical Trial page
- Check5 days agoChange DetectedLocations section updated to include state-specific entries and related topics Melanoma and MedlinePlus Genetics. The page revision was updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRemoved Melanoma and related topics: MedlinePlus Genetics from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedThe additions include Melanoma and MedlinePlus Genetics as related topics, and the PubMed publications note was revised accordingly. The deletions remove older wording about PubMed publications and the page revision tag changed from v3.2.0 to v3.3.2; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedThe government funding disclaimer banner at the top of the page has been removed. The study details, contacts, and locations remain unchanged.SummaryDifference0.3%

- Check55 days agoChange DetectedNo significant changes detected in the study page content; study details, eligibility criteria, and outcomes appear unchanged.SummaryDifference0.3%

- Check62 days agoChange DetectedDeleted the Melanoma term and the MedlinePlus Genetics topic from the page, removing core disease context and related resources.SummaryDifference0.1%

Stay in the know with updates to Combination Immunotherapy for Melanoma Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Immunotherapy for Melanoma Brain Metastases Clinical Trial page.